Ready to navigate the future of Pricing & Market Access (P&MA) trends in Pharma? Discover how emerging policies and new access models in key healthcare markets will reshape the global pharma landscape in 2025 and beyond.
Join us for the next episode of the Simon-Kucher Better Market Access webinar series, where we’ll dive into the latest developments in pharma P&MA in key healthcare markets. This session will provide hot-off-the-press insights into key reforms and policy changes to help you prepare for an evolving industry landscape in 2025.
Our expert Dominic Seitz will be joined by regional subject matter experts to answer your questions!
This webinar will cover:
- Healthcare reforms brought underway in Europe and Canada in 2024 which will come (partly) into effect in 2025, leading to impact on HTA, pricing, and access
- Deep-dive on major European markets providing tangible insights for HTA, pricing, reimbursement, and access launch pricing under new market realities
- Emerging market trends in China driving faster regulatory approval, NRDL process stability and price transparency, and broader early access pathways, as well as increasing momentum and adoption of commercial health insurance programs
- New HTA evaluation framework and access pathways in Saudi-Arabia, increasing requirements for access, while providing new strategic options to expedite access
Event Details:
To accommodate different time zones, we are offering two identical sessions:
- January 29: 10:00 – 11:00 a.m. CET | 5:00 – 6:00 p.m. SGT
- January 30: 5:00 – 6:00 p.m. CET | 11:00 a.m. – 12:00 p.m. EST
This webinar is free of charge. Don’t miss this opportunity to gain insights from our industry experts and get ready for a new P&MA era!
